Metrikler
Yayın
25
Açık Erişim
12
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (20)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (20)
Scopus (19)
TRDizin (3)
2024
20241. A Post-International Gastrointestinal Cancers Conference (IGICC) Position Statements '
YALÇIN Ş., Lacin S., Kaseb A. O., PEYNİRCİOĞLU B., Cantasdemir M., ÇİL B. E., et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA
, cilt.11, ss.953-974, 2024 (SCI-Expanded, Scopus)
2021
20212. Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma
PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH
, cilt.107, 2021 (SCI-Expanded, Scopus)
2021
20213. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study
Karadurmus N., PAYDAŞ S., Esin E., Surmeli Z. G., Yildiz B., Erturk I., et al.
ARCHIVES OF MEDICAL SCIENCE
, cilt.17, sa.4, ss.920-927, 2021 (SCI-Expanded, Scopus)
2021
20214. The prognostic significance of microsatellite status and its relationship with tumor-infiltrating lymphocyte in endometrial cancer
Lacin S., TAŞAR KAPAKLI G. E., USUBÜTÜN A., ARIK Z., YÜCE D., SALMAN M. C., et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, cilt.42, sa.3, ss.541-547, 2021 (SCI-Expanded, Scopus)
2021
20215. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma
PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH
, cilt.102, 2021 (SCI-Expanded, Scopus)
2021
20216. V600E and Non-V600E BRAF Mutations in Colorectal Cancer: Clinicopathologic Correlations in a Single Institution
ŞİMŞEK C., LAÇİN Ş., Ece E., YALÇIN Ş.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.31, sa.1, ss.43-49, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
20207. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S., YALÇIN Ş., Karakas Y., Hassan M. M., Amin H., Mohamed Y. I., et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA
, cilt.7, ss.143-153, 2020 (SCI-Expanded)
2020
20208. The Effects of Different Treatment Modalities on the Disease Course and Survival in Patients with Hepatocellular Cancer
Lacin S., Karakas Y., DİZDAR Ö., KILIÇKAP S., Hassan M. M., Xiao L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.30, sa.2, ss.94-102, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
20199. Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients
Guven D. C., DİZDAR Ö., ALP A., AKDOĞAN KITTANA F. N., KARAKOÇ D., HAMALOĞLU E., et al.
BIOMARKERS IN MEDICINE
, cilt.13, sa.9, ss.725-735, 2019 (SCI-Expanded, Scopus)
2018
201810. Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey
ESİN E., YILDIZ F., Lacin S., KARAKAS Y., GÜLTEKİN M., DİZDAR Ö., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.4, ss.411-418, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201811. Prognostic significance of periostin in patients with hepatocellular carcinoma
Kaseb A. O., Abugabal Y. I., Abdel-Wahab R., Lacin S., Botrus G., Pestana R. C., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)
2018
201812. Utility of Neuropilin-1 in predicting survival in patients with hepatocellular carcinoma
Abugabal Y. I., Hassan M., Abdel-Wahab R., Lacin S., Pestana R. C., Wolff R. A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)
2018
201813. Recent advances in the management of pancreatic adenocarcinoma
Karakas Y., LAÇİN Ş., YALÇIN Ş.
EXPERT REVIEW OF ANTICANCER THERAPY
, cilt.18, sa.1, ss.51-62, 2018 (SCI-Expanded, Scopus)
2017
201714. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma
Hassan M. M., Botrus G., Abdel-Wahab R., Wolff R. A., Li D., Tweardy D., et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
, cilt.15, sa.11, ss.1791-1799, 2017 (SCI-Expanded, Scopus)
2017
201715. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers
Karakas Y., KERTMEN N., LAÇİN Ş., Aslan A., DEMİR M., ATEŞ Ö., et al.
JOURNAL OF BUON
, cilt.22, sa.3, ss.623-627, 2017 (SCI-Expanded, Scopus)
2017
201716. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States
Al-Shamsi H. O., Abdel-Wahab R., Hassan M. M., Shalaby A. S., Dahbour I., Lacin S., et al.
ONCOLOGY
, cilt.93, sa.4, ss.233-242, 2017 (SCI-Expanded, Scopus)
2016
201617. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
Kaseb A. O., Hassan M., Lacin S., Abdel-Wahab R., Amin H. M., Shalaby A., et al.
ONCOTARGET
, cilt.7, sa.43, ss.69916-69926, 2016 (SCI-Expanded, Scopus)
2016
201618. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience
Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus)
2016
201619. A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y., Esin E., LAÇİN Ş., Ceyhan K., HEPER A., YALÇIN Ş.
ONCOTARGETS AND THERAPY
, cilt.9, ss.4815-4820, 2016 (SCI-Expanded, Scopus)
2015
201520. Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
LAÇİN Ş., Esin E., Karakas Y., YALÇIN Ş.
ONCOTARGETS AND THERAPY
, cilt.8, ss.1039-1042, 2015 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients?
Lacin S., Tasar G. E., Usubutun A., Arik Z., Karakas Y., Yuce D., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)
2017
20172. Erythropoietin and hepatocellular carcinoma: What is patients survival outcome?
Abdel-Wahab R., Hassan M., Lacin S., Shalaby A. S., Afshar-Kharghan V., Kaseb A. O.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)
2017
20173. Association of elevated alpha-1 antitrypsin with advanced clinicopathologic features of hepatocellular carcinoma
Abdel-Wahab R., Hassan M., Wolff R. A., Lacin S., Al-Shamsi H. O., Raghav K. P. S., et al.
53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)
2015
20154. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.
Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20155. The retrospective analysis of central nervous system lymphomas: Single-center experience.
Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)